2m 2m 2m 2m 2m 2m 2m
CRD-A-144A-S-AI (CRDL)
NASDAQ
$1.33+$0.01 (+1.15%)
Price as of Aug 03, 2026 7:59 PM EDT- $147.2MMarket Cap
- 2.34%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
CRD-A-144A-S-AI (CRDL)
$1.33+$0.01 (+1.15%)
CRDL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.31 | ||
Change | +$0.04 (+3.15%) | ||
Open | $1.29 | ||
High | $1.33 | ||
Low | $1.21 | ||
Previous Close | $1.27 | ||
Volume | 778,736 | ||
30-Day Average Volume | 955,638 | ||
1-Week Change | 13.42% | ||
1-Month Change | 24.76% | ||
1-Year Change | 2.34% | ||
3-Year Change | 12.93% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 115.2M | ||
Total Assets | $23.6M | ||
Market Cap | $147.2M | ||
Enterprise Value | $125.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue